The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 was enacted to regulate online prescriptions of controlled substances. The act requires that all providers prescribing controlled substances must conduct an in-person medical evaluation before they can write a prescription for their patient. Once the provider has conducted an initial in-person medical evaluation, they may continue to see the patient and write prescriptions via telemedicine.
The requirement of in-person evaluations in the Ryan Haight Act was waived due to the Covid-19 pandemic public health emergency, permitting our providers to care for patients, including you, all across Pennsylvania via telemedicine. This waiver is set to expire in May 2023, and once this requirement is reinstated, you will need to see your psychiatrist in-person before they can write prescriptions for controlled substances.
Advocate! Below are instructions for how you can contact your Members of Congress, the President, and the DEA to advocate that the requirement of in-person evaluations prior to prescribing controlled substances continue to be waived, or that a new exception to the law be written.
Use the following email template and send to : (opens in a new tab)
Contacting Members of Congress
Find your Members of Congress and their contact information
For Postal Correspondence:
For Email Correspondence:
For Phone Calls:
For Postal Correspondence
The White House
1600 Pennsylvania Ave, N.W.
Washington, DC 20500
For Email Correspondence
For Phone Calls